MENU
EPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Eupraxia Pharmaceuticals (EPRX) Earnings Date & Reports

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals... Show more

A.I. Advisor
published Earnings

EPRX is expected to report earnings to fall 4.90% to -18 cents per share on August 11

Eupraxia Pharmaceuticals EPRX Stock Earnings Reports
Q2'25
Est.
$-0.18
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.01
The last earnings report on May 06 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 5.12K shares outstanding, the current market capitalization sits at 188.11M.
View a ticker or compare two or three
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EPRX showed earnings on May 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201-2067 Cadboro Bay Road
Phone
+1 250 590-3968
Employees
21
Web
https://www.eupraxiapharma.com